Letermovir for cytomegalovirus prevention in adolescent patients following hematopoietic cell transplantation Journal Article


Authors: Daukshus, N. P.; Cirincione, A.; Siver, M.; Mathew, S.; Kunvarjee, B.; Chan, A.; Boelens, J. J.; Seo, S. K.; Papanicolaou, G. A.; Kernan, N. A.
Article Title: Letermovir for cytomegalovirus prevention in adolescent patients following hematopoietic cell transplantation
Abstract: There are limited data for letermovir as primary cytomegalovirus (CMV) prophylaxis in patients less than 18 years of age. We report 9 adolescent patients who received letermovir following hematopoietic cell transplantation. No patients developed clinically significant CMV while taking letermovir. Letermovir was well tolerated and efficacious in preventing CMV infections. © The Author(s) 2022. Published by Oxford University Press on behalf of The Journal of the Pediatric Infectious Diseases Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Keywords: cytomegalovirus; adolescents; hematopoietic cell transplant; letermovir
Journal Title: Journal of the Pediatric Infectious Diseases Society
Volume: 11
Issue: 7
ISSN: 2048-7193
Publisher: Oxford University Press  
Date Published: 2022-07-01
Start Page: 337
End Page: 340
Language: English
DOI: 10.1093/jpids/piac017
PUBMED: 35472147
PROVIDER: scopus
PMCID: PMC9989834
DOI/URL:
Notes: Article -- Export Date: 1 August 2022 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Nancy Kernan
    512 Kernan
  2. Susan Seo
    120 Seo
  3. Sherry Mathew
    19 Mathew
  4. Amelia   Chan
    12 Chan
  5. Jaap Jan Boelens
    204 Boelens